A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma
 
Sponsors and Collaborators
Emory University
Multiple Myeloma Research Consortium
Novartis
Onyx Therapeutics, Inc.
 
Contact
Jonathan Kaufman, MD
1-888-946-7447
 
Investigator
Jonathan Kaufman, MD
Emory University Winship Cancer Institute
 
ClinicalTrials.gov Identifier